Oncologix Tech Stock Buy Hold or Sell Recommendation
| OCLG Stock | USD 0.0001 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Oncologix Tech is 'Strong Sell'. Macroaxis provides Oncologix Tech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OCLG positions.
Check out Oncologix Tech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Oncologix and provide practical buy, sell, or hold advice based on investors' constraints. Oncologix Tech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Oncologix |
Execute Oncologix Tech Buy or Sell Advice
The Oncologix recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Oncologix Tech. Macroaxis does not own or have any residual interests in Oncologix Tech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Oncologix Tech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Oncologix Tech Trading Alerts and Improvement Suggestions
| Oncologix Tech generated a negative expected return over the last 90 days | |
| Oncologix Tech has some characteristics of a very speculative penny stock | |
| Oncologix Tech has a very high chance of going through financial distress in the upcoming years | |
| Oncologix Tech currently holds 3.97 M in liabilities. Oncologix Tech has a current ratio of 0.27, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Oncologix Tech until it has trouble settling it off, either with new capital or with free cash flow. So, Oncologix Tech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Oncologix Tech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Oncologix to invest in growth at high rates of return. When we think about Oncologix Tech's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2.85 M. Net Loss for the year was (2.37 M) with profit before overhead, payroll, taxes, and interest of 614.41 K. | |
| Oncologix Tech currently holds about 86.31 K in cash with (24.2 K) of positive cash flow from operations. |
Oncologix Tech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Oncologix Tech or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Oncologix Tech's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Oncologix pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Oncologix Tech Volatility Alert
At this time Oncologix Tech exhibits very low volatility. Oncologix Tech appears to be a penny stock. Although Oncologix Tech may be, in fact, a solid short-term or long term investment, many penny pink sheets are speculative investment instruments that are often subject to artificial stock promotion and campaigns of hype which may lead to misinformation and misrepresentation. Please make sure you fully understand upside potential and downside risks of investing in Oncologix Tech or similar risky assets. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswing without any event/news,and sudden news releases. We also encourage traders to check biographies and work history of company President, CEO or other officers before investing in high-volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Oncologix instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Oncologix Tech Fundamentals Vs Peers
Comparing Oncologix Tech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Oncologix Tech's direct or indirect competition across all of the common fundamentals between Oncologix Tech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Oncologix Tech or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Oncologix Tech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Oncologix Tech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Oncologix Tech to competition |
| Fundamentals | Oncologix Tech | Peer Average |
| Return On Asset | -0.12 | -0.14 |
| Profit Margin | (0.38) % | (1.27) % |
| Operating Margin | (0.13) % | (5.51) % |
| Current Valuation | 3.18 M | 16.62 B |
| Shares Outstanding | 340.13 M | 571.82 M |
| Price To Earning | (0.03) X | 28.72 X |
| Price To Sales | 0.17 X | 11.42 X |
| Revenue | 2.85 M | 9.43 B |
| Gross Profit | 614.41 K | 27.38 B |
| EBITDA | (572.25 K) | 3.9 B |
| Net Income | (2.37 M) | 570.98 M |
| Cash And Equivalents | 86.31 K | 2.7 B |
| Total Debt | 3.97 M | 5.32 B |
| Current Ratio | 0.28 X | 2.16 X |
| Book Value Per Share | (0) X | 1.93 K |
| Cash Flow From Operations | (24.2 K) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Number Of Employees | 191 | 18.84 K |
| Beta | 1.27 | -0.15 |
| Market Capitalization | 612.23 K | 19.03 B |
| Total Asset | 1.5 M | 29.47 B |
| Retained Earnings | (49.86 M) | 9.33 B |
| Working Capital | (3.35 M) | 1.48 B |
| Current Asset | 1.31 M | 9.34 B |
| Current Liabilities | 4.67 M | 7.9 B |
| Z Score | -47.6 | 8.72 |
| Net Asset | 1.5 M |
Oncologix Tech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Oncologix . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
About Oncologix Tech Buy or Sell Advice
When is the right time to buy or sell Oncologix Tech? Buying financial instruments such as Oncologix Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Oncologix Tech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tech Growth Thematic Idea Now
Tech Growth
Instruments that are typically traded at high earnings multiples compared to their competitors and other sectors and have been known to drive market cycles frequently. The Tech Growth theme has 66 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Growth Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Oncologix Pink Sheet
Oncologix Tech financial ratios help investors to determine whether Oncologix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncologix with respect to the benefits of owning Oncologix Tech security.